neutral
Recently
Curis Lifesciences schedules Q3 FY26 earnings concall for January 3
Curis Lifesciences will hold its Q3 FY26 earnings concall on January 3 after reporting H1 revenue of ₹15.9 crore and operating margin near 24%.
Curis Lifesciences announced an earnings conference call scheduled for January 3, 2026, following the release of its Q3 FY26 financial results. In H1 FY26, the pharma company reported revenue of ₹15.90 crore and operating profit of ₹3.81 crore, translating into an operating margin of about 24%. Investors will track updates on product development and pipeline progress during the interaction.